arrow
G

Graeme J. Hankey

Royal Perth Hospital
H指数:165
被引数:29.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Healing Right Way: A Stepped Wedge Cluster Randomised Controlled Trial Aiming to Enhance Quality of Life for Aboriginal Australian Survivors of Stroke and Traumatic Brain Injury

疗愈正道:一项旨在提升澳大利亚原住民中风和创伤性脑损伤幸存者生活质量的阶梯楔形整群随机对照试验

2025-10-010
OAAI
Influence of age on the association of vascular risk factors with acute stroke (INTERSTROKE): a case–control study

年龄对血管危险因素与急性卒中关联性的影响(INTERSTROKE):一项病例对照研究

2025-07-020
OA
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)
2025-02-010
OAAI
Sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses

与男性计算的游离睾酮浓度相关的社会人口统计学、生活方式和医学因素: 个体参与者数据荟萃分析

2024-11-221
OAAI
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
2024-11-015
OAAI
Carbonated Beverage, Fruit Drink, and Water Consumption and Risk of Acute Stroke: the INTERSTROKE Case-Control Study
stroke
IF8.6
2024-09-300
OAAI
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial
2024-06-266
OAAI
Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study

澳大利亚70岁及以上成年人的预期寿命、死亡率和疾病负担: 全球疾病负担2019研究的系统分析

2024-06-010
OAAI
Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men: Individual Participant Data Meta-analyses

睾酮和相关激素与男性全因死亡率和心血管疾病发病率的关系: 个体参与者数据荟萃分析

2024-06-0111
PRE
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case-control study
2024-04-012
OAAI